Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
5.33
-0.37 (-6.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Cadrenal Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 16 | 16 | 26 | 10 | - |
| Market Cap Growth | -41.81% | -38.62% | 168.05% | - | - |
| Enterprise Value | 12 | 12 | 21 | 1 | - |
| Last Close Price | 5.33 | 6.78 | 14.49 | 11.10 | - |
| PB Ratio | 4.55 | 5.79 | 3.47 | 1.25 | - |
| P/TBV Ratio | 5.99 | 5.79 | 3.47 | 1.25 | - |
| Debt / Equity Ratio | - | - | - | 0.00 | -0.11 |
| Net Debt / Equity Ratio | -1.46 | -1.46 | -1.35 | -1.09 | -0.11 |
| Net Debt / EBITDA Ratio | 0.30 | 0.30 | 0.91 | 1.10 | -0.21 |
| Net Debt / FCF Ratio | 0.32 | 0.32 | 1.36 | 2.37 | -0.46 |
| Quick Ratio | 2.53 | 2.53 | 3.75 | 10.21 | 0.02 |
| Current Ratio | 2.72 | 2.72 | 3.77 | 10.27 | 0.55 |
| Return on Equity (ROE) | -260.11% | -260.11% | -140.78% | -780.59% | - |
| Return on Assets (ROA) | -116.44% | -116.44% | -73.49% | -102.62% | - |
| Return on Capital Employed (ROCE) | -491.50% | -491.50% | -147.30% | -99.20% | 529.80% |
| Earnings Yield | -80.68% | -83.50% | -41.24% | -86.73% | - |
| FCF Yield | -76.84% | -79.53% | -28.51% | -36.67% | - |
| Buyback Yield / Dilution | -63.48% | -63.48% | -35.59% | -70.99% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.